Neuroendocrine neoplasms of head and neck, genitourinary and gynaecological systems, unknown primaries, parathyroid carcinomas and intrathyroid thymic neoplasms: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
ESMO Open 2024;9(10):103664
Hadoux J, Lamarca A, Grande E, et al., on behalf of the ESMO Guidelines Committee
- This Clinical Practice Guideline provides key recommendations for managing rare endocrine tumours.
- Neuroendocrine neoplasms of different origins, parathyroid carcinoma and intrathyroid thymic neoplasms are included.
- The guideline covers clinical imaging and pathological diagnosis, staging and risk assessment, treatment and follow-up.
- The authors comprise a multidisciplinary group of experts from different institutions and countries in Europe.
- Recommendations are based on available scientific data and the authors’ collective expert opinion.